Clinical and microbiological factors associated with mortality in candidemia in adult patients 2007–2016

References

• Arendrup MC, Sulim S, Holm A, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011;49(9):3300–3308.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41(9):1232–1239.
   PubMed Web of Science ®Google Scholar
• Boo TW, O'reilly B, O'leary J, et al. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors. Mycoses. 2005;48(4):251–259.
   PubMed Web of Science ®Google Scholar
• Puig-Asensio M, Padilla B, Garnacho-Montero J, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20(4):O245–O254.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Merelli M, Righi E, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol. 2013;51(12):4167–4172.
   PubMed Web of Science ®Google Scholar
• Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(Suppl 6):5–10.
   Web of Science ®Google Scholar
• Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14(11):e954–e966.
   PubMed Web of Science ®Google Scholar
• Matsumoto E, Boyken L, Tendolkar S, et al. Candidemia surveillance in Iowa: emergence of echinocandin resistance. Diagn Microbiol Infect Dis. 2014;79(2):205–208.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006;6:21.
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445–1456.
   PubMed Web of Science ®Google Scholar
• McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med. 1962;10(6):847–855.
   Google Scholar
• Ala-Houhala M, Koukila-Kahkola P, Antikainen J, et al. Clinical use of fungal PCR from deep tissue samples in the diagnosis of invasive fungal diseases: a retrospective observational study. Clin Microbiol Infect. 2018;24(3):301–305.
   PubMed Web of Science ®Google Scholar
• Poikonen E, Lyytikainen O, Anttila VJ, et al. Secular trend in candidemia and the use of fluconazole in Finland, 2004–2007. BMC Infect Dis. 2010;10:312.
   PubMed Web of Science ®Google Scholar
• Hesstvedt L, Gaustad P, Andersen CT, et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect. 2015;21(10):938–945.
   PubMed Web of Science ®Google Scholar
• Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol. 2013;51(3):841–848.
   PubMed Web of Science ®Google Scholar
• Ericsson J, Chryssanthou E, Klingspor L, et al. Candidaemia in Sweden: a nationwide prospective observational survey. Clin Microbiol Infect. 2013;19(4):E218–E221.
   PubMed Web of Science ®Google Scholar
• Hesstvedt L, Arendrup MC, Poikonen E, et al. Differences in epidemiology of candidaemia in the Nordic countries - what is to blame? Mycoses. 2017;60(1):11–19.
   PubMed Web of Science ®Google Scholar
• Cleveland AA, Harrison LH, Farley MM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS ONE. 2015;10(3):e0120452.
   PubMed Web of Science ®Google Scholar
• Jia X, Li C, Cao J, et al. Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study. Eur J Clin Microbiol Infect Dis. 2018;37(9):1717–1724.
   PubMed Web of Science ®Google Scholar
• Morii D, Seki M, Binongo JN, et al. Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan. J Infect Chemother. 2014;20(9):558–562.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816–2823.
   PubMed Web of Science ®Google Scholar
• Rodriguez L, Bustamante B, Huaroto L, et al. A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PLoS ONE. 2017;12(4):e0175172.
   PubMed Web of Science ®Google Scholar
• Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008;46(8):1206–1213.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Ansaldi F, Nicolini L, et al. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother. 2009;64(3):625–629.
   PubMed Web of Science ®Google Scholar
• Montagna MT, Caggiano G, Lovero G, et al. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection. 2013;41(3):645–653.
   PubMed Web of Science ®Google Scholar
• Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640–3645.
   PubMed Web of Science ®Google Scholar
• Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43(1):25–31.
   PubMed Web of Science ®Google Scholar
• Parkins MD, Sabuda DM, Elsayed S, et al. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother. 2007;60(3):613–618.
   PubMed Web of Science ®Google Scholar
• Kludze-Forson M, Eschenauer GA, Kubin CJ, et al. The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection. Med Mycol. 2010;48(2):436–439.
   PubMed Web of Science ®Google Scholar
• Hesstvedt L, Gaustad P, Muller F, et al. The impact of age on risk assessment, therapeutic practice and outcome in candidemia. Infect Dis (Lond). 2019;51(6):425–434.
   PubMed Web of Science ®Google Scholar